Literature DB >> 7722172

Immune function in cigarette smokers who quit smoking for 31 days.

C J Meliska1, M E Stunkard, D G Gilbert, R A Jensen, J M Martinko.   

Abstract

A group of 28 healthy, white, male, light-to-moderate smokers, 21 to 35 years of age, were offered a financial inducement to abstain from smoking for 31 days. A matched control group of 11 smokers were paid to continue smoking during the same period. Nonspecific parameters of immune system function were monitored before and at various times after smoking abstinence. Abstinence increased natural killer cell cytotoxic activity but did not alter mitogen-induced T-lymphocyte proliferation as measured by responses to concanavalin A or phytohemagglutinin. Serum cortisol concentrations also decreased after smoking cessation; however, changes in immune function were not correlated with serum cortisol change, nor with indices of smoking such as plasma nicotine and cotinine levels. Responses to concanavalin A and phytohemagglutinin were positively correlated with change in self-reported alcohol ingestion during smoking abstinence. Results indicate that elevation in natural kill cell cytotoxic activity is detectable within 1 month of smoking cessation, even in light-to-moderate smokers. However, elevation in natural killer cell cytotoxic activity appears not to be directly related to cessation-induced reductions in plasma nicotine, cotinine, or circulating cortisol levels.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7722172     DOI: 10.1016/s0091-6749(95)70135-4

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  18 in total

1.  Smoking and Liver Disease.

Authors:  Stephanie M Rutledge; Amon Asgharpour
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-12

Review 2.  Biobehavioral outcomes following psychological interventions for cancer patients.

Authors:  Barbara L Andersen
Journal:  J Consult Clin Psychol       Date:  2002-06

Review 3.  Heavy smoking and liver.

Authors:  Abdel-Rahman El-Zayadi
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

4.  Does smoking explain sex differences in the global tuberculosis epidemic?

Authors:  R E Watkins; A J Plant
Journal:  Epidemiol Infect       Date:  2006-04       Impact factor: 2.451

5.  Lifestyle, stress and cortisol response: Review II : Lifestyle.

Authors:  S Fukuda; K Morimoto
Journal:  Environ Health Prev Med       Date:  2001-04       Impact factor: 3.674

6.  Effect of low to moderate levels of smoking and alcohol consumption on serum immunoglobulin concentrations.

Authors:  S A McMillan; J P Douglas; G P Archbold; E E McCrum; A E Evans
Journal:  J Clin Pathol       Date:  1997-10       Impact factor: 3.411

Review 7.  Stimuli-induced organ-specific injury enhancement of organotropic metastasis in a spatiotemporal regulation.

Authors:  Dongwei Gao; Sha Li
Journal:  Pathol Oncol Res       Date:  2013-12-20       Impact factor: 3.201

8.  Decreased serum antibody responses to recombinant pneumocystis antigens in HIV-infected and uninfected current smokers.

Authors:  Kristina Crothers; Kieran R Daly; David Rimland; Matthew Bidwell Goetz; Cynthia L Gibert; Adeel A Butt; Amy C Justice; Kpandja Djawe; Linda Levin; Peter D Walzer
Journal:  Clin Vaccine Immunol       Date:  2010-12-29

9.  IL-10 -1082 G>A: a risk for prostate cancer but may be protective against progression of prostate cancer in North Indian cohort.

Authors:  Pravin Kesarwani; Dinesh Kumar Ahirwar; Anil Mandhani; Anand Narayan Singh; Divakar Dalela; Anand Narain Srivastava; Rama D Mittal
Journal:  World J Urol       Date:  2009-01-15       Impact factor: 4.226

10.  Transcriptomic epidemiology of smoking: the effect of smoking on gene expression in lymphocytes.

Authors:  Jac C Charlesworth; Joanne E Curran; Matthew P Johnson; Harald Hh Göring; Thomas D Dyer; Vincent P Diego; Jack W Kent; Michael C Mahaney; Laura Almasy; Jean W MacCluer; Eric K Moses; John Blangero
Journal:  BMC Med Genomics       Date:  2010-07-15       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.